{
"id":"mk19_a_nr_t26",
"number":26,
"bookId":"nr",
"title":{
"__html":"Contraindications to Intravenous Alteplase in Adults with Acute Ischemic Stroke"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"ae35ac",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 26. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t26"
}
]
},
"Contraindications to Intravenous Alteplase in Adults with Acute Ischemic Stroke"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d4ae29",
"class":"col hd l",
"children":[
"Absolute Exclusion Criteria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd321c",
"class":"col hd l",
"children":[
"Relative Exclusion Criteria"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"76c7f5",
"class":"cell txt l",
"children":[
"Significant head trauma or prior stroke in the previous 3 months"
]
},
" ",
{
"type":"p",
"hlId":"928de3",
"class":"cell txt l",
"children":[
"Suspicion of subarachnoid hemorrhage"
]
},
" ",
{
"type":"p",
"hlId":"c7827c",
"class":"cell txt l",
"children":[
"Noncompressible site arterial puncture within 7 days"
]
},
" ",
{
"type":"p",
"hlId":"c04476",
"class":"cell txt l",
"children":[
"Intracranial neoplasm, arteriovenous malformation, aneurysm"
]
},
" ",
{
"type":"p",
"hlId":"69338f",
"class":"cell txt l",
"children":[
"Recent intracranial or spinal surgery"
]
},
" ",
{
"type":"p",
"hlId":"d28fc9",
"class":"cell txt l",
"children":[
"Blood pressure ≥185/110 mm Hg despite treatment"
]
},
" ",
{
"type":"p",
"hlId":"25a0d4",
"class":"cell txt l",
"children":[
"Active internal bleeding"
]
},
" ",
{
"type":"p",
"hlId":"129f24",
"class":"cell txt l",
"children":[
"Active bleeding diathesis"
]
},
" ",
{
"type":"p",
"hlId":"5d349b",
"class":"cell txt li",
"children":[
"Platelet count 100,000/μL (100 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L)"
]
},
" ",
{
"type":"p",
"hlId":"33eaab",
"class":"cell txt li",
"children":[
"Heparin within 48 hours with an activated partial thromboplastin time above normal range"
]
},
" ",
{
"type":"p",
"hlId":"601b0e",
"class":"cell txt li",
"children":[
"Current use of anticoagulant with INR >1.7"
]
},
" ",
{
"type":"p",
"hlId":"11bf48",
"class":"cell txt li",
"children":[
"Current use of non–vitamin K antagonist anticoagulants (within 48 hours) with associated elevated relevant laboratory tests"
]
},
" ",
{
"type":"p",
"hlId":"5f000e",
"class":"cell txt l",
"children":[
"Blood glucose less 50 mg/dL (2.8 mmol/L)"
]
},
" ",
{
"type":"p",
"hlId":"0f2cec",
"class":"cell txt l",
"children":[
"Noncontrast head CT demonstrated multi-lobar infarction with >1/3 of the hemisphere involved"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28ee12",
"class":"cell txt l",
"children":[
"Minor or rapidly improving nondisabling symptoms",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" ",
{
"type":"p",
"hlId":"0b1e9b",
"class":"cell txt l",
"children":[
"Pregnancy"
]
},
" ",
{
"type":"p",
"hlId":"ee9e18",
"class":"cell txt l",
"children":[
"Seizure at onset"
]
},
" ",
{
"type":"p",
"hlId":"bdd592",
"class":"cell txt l",
"children":[
"Major surgery or serious trauma within 14 days"
]
},
" ",
{
"type":"p",
"hlId":"9f9bf6",
"class":"cell txt l",
"children":[
"Recent gastrointestinal or genitourinary bleeding within 21 days"
]
},
" ",
{
"type":"p",
"hlId":"4e5c70",
"class":"cell txt l",
"children":[
"Recent acute myocardial infarction"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Disabling symptoms are defined as complete hemianopia (score of 2-3 on National Institutes of Health Stroke Scale [NIHSS] question 3), visual or sensory extinction (score of 1-2 on NIHSS question 11), any weakness against gravity (score of 2-4 on NIHSS question 6 or 7), and total NIHSS score >5."
],
[
"Adapted from Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al; American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016;47:581-641. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26696642",
"target":"_blank"
},
"children":[
"PMID: 26696642"
]
},
" doi:10.1161/STR.0000000000000086"
]
]
}